MARSEILLE, France, October 05, 2023 Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the lacutamab IND leading to a pause in new patient enrollment to the Company’s ongoing lacutamab trials IPH4102-201 (Phase 2 TELLOMAK) and 102 (Phase 1b PTCL). The partial clinical hold follows one fatal case of hemophagocytic lymphohistiocytosis (HLH), a rare
Robust decreases in serum IgM at low- and mid-doses suggest best-in-class potential for mavorixafor plus ibrutinib therapy in double-mutation Waldenström’s patients; meaningful increases in hemoglobin levels suggest reduction in cancer burden in bone marrow At 6 months, patients achieved median IgM level reductions of 60%-75%, with one patient achieving normal IgM, and two of four patients (50%) had >50% reduction in IgM from baseline e-Poster now available online; pre-recorded presentation by l
New guidance from the Centers for Disease Control and Prevention indicates a recent study found no obvious safety signals surrounding vaccination in pregnant women.
The researchers looked at data from 35,691 women, who ranged in age from 16 to 54, in a peer-reviewed study published this week in The New England Journal of Medicine. Data used in the research was self-reported using the v-safe after vaccination health checker, researchers noted. No safety concerns were observed for people vaccinated in the third trimester or safety concerns for their babies, CDC Director Dr. Rochelle Walensky said Friday. As such, CDC recommends pregnant people receive COVID-19 vaccines.
Disability sector labels wait for COVID-19 vaccines shameful
updated 4
The disability sector is frustrated at the lack of transparency over vaccine data.
(
Print text only
Cancel
As Australia enters its eighth week of the COVID-19 vaccine rollout, thousands of the nation s most vulnerable are still waiting for their first dose.
Key points:
One of Australia s largest disability service providers says they are yet to receive a single dose of coronavirus vaccines
Residents and workers in specialist disability accommodation were placed in Phase 1A of the rollout
At the end of March, vaccinations had been administered to 50 residential disability facilities
It is a situation leaders in the disability sector have labelled shameful , demanding to know when vaccines will be delivered.